BriaCell Therapeutics amends articles after share exchange under arrangement

BriaCell Therapeutics Corp.

Amended notice of articles and articles effective August 31, 2023.
All existing BriaCell common shares exchanged for new shares with identical rights.
Outstanding share count remains 15,981,726 following the exchange.
Shareholders retain one vote per share and dividend/liquidation rights unchanged.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BriaCell Therapeutics Corp.: Amended notice of articles and articles to effect share exchange pursuant to arrangement agreement (effective 2023-08-31).

Change: charter amendment
Effective: 2023-08-31

Exact text from the filing

On August 31, 2023, 2023, BriaCell Therapeutics Corp. (the “Company”) amended its articles pursuant to the previously disclosed arrangement agreement (the “Agreement”).

View on SEC.gov

Browse all governance changes →

BriaCell Therapeutics Corp. filing history →

Source: SEC EDGAR

accession 0001493152-23-031982

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.